A carregar...
Self-Limited Cytomegalovirus Infection During Natalizumab Treatment for Multiple Sclerosis
Natalizumab is indicated as monotherapy for the treatment of relapsing-remitting multiple sclerosis; it prevents outbreaks and delays the progression of physical disability. Here, we report the case of a 30-year-old patient with multiple sclerosis receiving natalizumab as monotherapy who subsequentl...
Na minha lista:
| Publicado no: | Eur J Case Rep Intern Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SMC Media Srl
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6432828/ https://ncbi.nlm.nih.gov/pubmed/30931272 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12890/2019_001046 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|